Amer Alghabban, CEO and Managing Director of GxP Compliance & Training Partners (GCTP) Ltd. He founded GCTP in April 2013 helping pharmaceutical, Biotech companies & Academic Institutions with expertise to achieve compliance with GCP, GVP, GCLP and GLP as well as providing a variety of trainings in these disciplines. Amer provided over 20 companies support with regulatory inspections, preparing, hosting and managing the inspections, responses and remedial actions.
Prior to his current role, he was Director, Global Head of Quality Assurance & Audit Management at Merck Serono, Geneva, Switzerland. His previous positions include: Global Head of GxP (GCP, GMP, GLP and GVP) Quality Assurance at Arpida Ag., Switzerland, Senior International Clinical Quality Assurance Audit Manager at Novartis Pharma Headquarters in Switzerland. Amer was the first Pharmacovigilance Compliance Coordinator of the MHRA (UK Department of Health)
Amer is a frequently invited speaker at international congresses: has both presented & chaired at over 102 international congresses, academic institutions, as well as the WHO. He has over 27 years’ track record in the pharmaceutical industry (Clinical Development, Quality Assurance, Pharmacovigilance, Medical Information, & Medical Communications). For some time, he was the Assistant Editor for 11 Medical & Pharmaceutical journals. He contributed further to these disciplines by writing “The Pharmaceutical Medicine Dictionary” in April 2001 and “The Dictionary of Pharmacovigilance” in May 2004. He is currently writing his 3rd book, Dictionary of Clinical & Pharmaceutical Development.
Amer completed his M.Sc. in Pharmacology at Bradford University, Postgraduate studies in Medical Sciences at University College Hospital, Diploma in Biological Sciences from Salford University & Postgraduate Certificate in Clinical Research from Surrey University.